A Study to Evaluate the Safety and Effectiveness of Mirodenafil in Korean Patients With Erectile Dysfunction

NCT01802359 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 379

Last updated 2017-06-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of mirodenafil in participants with erectile dysfunction.

Conditions

Interventions

DRUG

No intervention

This is an observational study. Korean male participants receiving mirodenafil as per the prescribing information will be observed.

Sponsors & Collaborators

  • Janssen Korea, Ltd., Korea

    lead INDUSTRY

Principal Investigators

  • Janssen Korea, Ltd., Korea Clinical Trial · Janssen Korea, Ltd., Korea

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-07
Primary Completion
2012-05-31
Completion
2012-05-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01802359 on ClinicalTrials.gov